Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population

International Journal of Drug Policy

Volumn 38, Issue , 2016, Pages 16-20

  Lappin, Julia M ^a   Roxburgh, Amanda ^a   Kaye, Sharlene ^a,b   Chalmers, Jenny ^a   Sara, Grant ^b,c   Dobbins, Timothy ^a   Burns, Lucinda ^a   Farrell, Michael ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b New South Wales Government   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Crystal methamphetamine; Dependence; Drug induced psychosis; Methamphetamine; Psychosis; Schizophrenia; Stimulant

Indexed keywords

METHAMPHETAMINE;

ADULT; AGE; ARTICLE; AUSTRALIAN; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHAMPHETAMINE DEPENDENCE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SELF REPORT; SUBSTANCE USE; AMPHETAMINE DEPENDENCE; AUSTRALIA; BRIEF PSYCHIATRIC RATING SCALE; COMPLICATION; HIGH RISK BEHAVIOR; INTERVIEW; PSYCHOLOGY; RISK FACTOR;

ADULT; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; METHAMPHETAMINE; PREVALENCE; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; RISK-TAKING; SELF REPORT;

EID: 84995478885     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.10.018     Document Type: Article

References (29)

1. Bramness, J.G., Gundersen, Ø.H., Guterstam, J., Rognli, E.B., Konstenius, M., Løberg, E.M., et al. Amphetamine-induced psychosis—A separate diagnostic entity or primary psychosis triggered in the vulnerable?. BMC Psychiatry, 12, 2012, 221.
2. Callaghan, R.C., Cunningham, J.K., Allebeck, P., Arenovich, T., Sajeev, G., Remington, G., et al. Methamphetamine use and schizophrenia: A population-based cohort study in California. American Journal of Psychiatry 169:4 (2012), 389-396.
3. Cho, A.K., Ice: A new dosage form of an old drug. Science 249:4969 (1990), 631-634.
4. Connell, P.H., Amphetamine psychosis. Maudsley monograph no. 5. 1958, Chapman & Hall, London.
5. Cornish, J.W., O'Brien, C.P., Crack cocaine abuse: An epidemic with many public health consequences. Annual Review of Public Health 17 (1996), 259-273.
6. Darke, S., Kaye, S., McKetin, R., Doflou, J., Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 27 (2008), 253-262.
7. Degenhardt, L., Larney, S., Chan, G., Dobbins, T., Weier, M., Roxburgh, A., et al. Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014. Medical Journal of Australia 204 (2016), 153-156.
8. Degenhardt, L., Sara, G., McKetin, R., Roxburgh, A., Dobbins, T., Farrell, M., et al. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review, 2016, 10.1111/dar.12426 [Epub ahead of print].
9. Furukawa, T.A., Kessler, R.C., Slade, T., Andrews, G., The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine 33 (2003), 357-362.
10. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., Rawson, R., et al. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Journal of Substance Abuse Treatment 35:4 (2008), 445-450.
11. Hafner, H., Gender differences in schizophrenia. Psychoneuroendocrinology 28:s2 (2003), 17-54.
12. Hall, W., Hando, J., Darke, S., Ross, J., Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 91:1 (1996), 81-87.
13. IBM Corp. (Released 2013). IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.
14. Karila, L., Weinstein, A., Aubin, H., Benyamina, A., Reynaud, M., Batki, S.L., Pharmacological approaches to methamphetamine dependence: A focused review. British Journal of Clinical Pharmacology 69:6 (2010), 578-592.
15. Kessler, R.C., Andrews, G., Colpe, L.J., Hiripi, E., Mroczek, D.K., Normand, S.L., et al. Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychological Medicine 32 (2002), 959-976.
16. Kittirattanapaiboon, P., Mahatnirunkul, S., Booncharoen, H., Dumrongchai, U., Chutha, W., Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug and Alcohol Review 29 (2010), 456-461.
17. McKetin, R., McLaren, J., Kelly, E., The Sydney methamphetamine market: Patterns of supply, use, personal harms and social consequences. 2005, National Drug Law Enforcement Research Fund, Australia.
18. McKetin, R., McLaren, J., Lubman, D.I., Hides, L., The prevalence of psychotic symptoms among methamphetamine users. Addiction 101:10 (2006), 1473-1478.
19. McKetin, R., Hickey, K., Devlin, K., Lawrence, K., The risk of psychotic symptoms associated with recreational methamphetamine use. Drug and Alcohol Review 29:4 (2010), 358-363.
20. McKetin, R., Lubman, D.I., Baker, A.L., Dawe, S., Ali, R.L., Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study. JAMA Psychiatry 70 (2013), 319-324.
21. McGrath, J., Saha, S., Chant, D., Welham, J., Schizophrenia: A concise overview of incidence, prevalence and mortality. Epidemiologic Reviews 30 (2008), 67-76.
22. Medhus, S., Rognli, E., Gossop, M., Holm, B., Morland, J., Bramness, J.G., Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample. American Journal on Addictions 24 (2015), 586-589.
23. Moore, T.H., Zammit, S., Lingford-Hughes, A., Barnes, T.R., Jones, P.B., Burke, M., et al. Cannabis use and risk of psychosis or affective mental health outcomes: A systematic review. Lancet 370 (2007), 319-328.
24. Niemi-Pynttari, J.A., Putkonen, H., Vorma, H., Wahlbeck, K., Pirkola, S.P., Substance-induced psychoses converting into schizophrenia: A register-based study of 18,478 Finnish inpatient cases. Journal of Clinical Psychiatry 74:1 (2013), e94-9.
25. NSW Ministry of Health. Crystalline methamphetamine. Background paper - NSW data. September 2015 (revised). Sydney: NSW MoH, 2015. Retrieved 26 April 2016 from http://www.health.nsw.gov.au/crystallinemethamphetamine/Publications/background-paper.pdf.
26. Sara, G.E., Large, M.M., Matheson, S.L., Burgess, P.M., Malhi, G.S., Whiteford, H.A., et al. Stimulant use disorders in people with psychosis: A meta-analysis of rate and factors affecting variation. Australian and New Zealand Journal of Psychiatry 49:2 (2015), 106-117.
27. Smith, M.J., Thirthalli, J., Abdallah, A.B., Murray, R.M., Cottler, L.B., Prevalence of psychotic symptoms in substance users: A comparison across substances. Comprehensive Psychiatry 50:3 (2009), 245-250.
28. Stafford, J., Burns, L., Australian drug trends: Findings from the illicit drug reporting system., 2014, National Drug and Alcohol Research Centre, UNSW, Sydney.
29. Topp, L., Mattick, R., Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 92:7 (1997), 839-845.